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A bstract: A  simple, sensitive and reproducible ultra-performance liquid chromatography (UPLC) method for 
the determination of: danofloxacin, enrofloxacin, marbofloxacin, orbifloxacin and pefloxacin oxidation stabil­
ity under permanganate treatm ent in acidic conditions at pH  from 3.0 to 6.0, was developed. Chromatographic 
separations were carried out using the Acquity UPLC BEH C 1 8  column; (2.1 x  100 mm, 1.7 pm  particle size).
The colum n was maintained at 40OC, and eluted under gradient conditions using from 100% to 75% of eluent 
A  over 10 m in for danofloxacin, enrofloxacin, marbofloxacin, orbifloxacin or 95% to 75% o f eluent A  over 10 
m in for pefloxacin, at a flow rate o f 0.3 mL/min. E luent A: 1% (v/v) formic acid in water; eluent B: 0.1% (v/v) 
formic acid in acetonitrile. Satisfactory resolution was obtained for oxidation products. The correlation coeffi­
cients and determination coefficients (R2) obtained for linear model for all examined fluoroquinolones were 
greater than 0.99. Linearity range was observed in the concentration range 0.06-0.13 mg/mL. Sensitivity o f the 
m ethod was good. The LOD and LOQ values were found to be 0.01 mg/mL and from 0.02 to 0.04 mg/mL, 
respectively. Good precision and intermediate precision with %RSD less than 2.0% was observed. The oxida­
tion processes followed kinetic o f the second order reaction and depended upon solution acidity. Oxidation of 
fluoroquinolones proceeded at piperazine m oiety yielding respective hydroxy and oxo analogs, and leaving the 
quinolone fragment intact. Structures of products formed were assigned on a basis o f UPLC/M S/M S fragmen­
tation pathways.
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Fluoroquinolones are antimicrobial agents 
widely used in human and veterinary medicine due 
to their broad activity spectrum against Gram-posi­
tive and Gram-negative bacteria and good oral 
intake properties. After administration, fluoro­
quinolones are only partially metabolized in the 
body and largely excreted in their pharmacological­
ly active forms (1, 2).
In stability studies of pharmaceuticals, beside 
hydrolysis in acidic and basic solutions and verifica­
tion of photostability, evaluation of an influence of 
oxidizing agents has been recommended (3). It is 
worth noting, that the oxidation process of drugs, 
especially antibiotics, has focused more attention as 
an arising issue in the environmental protection.
The literature survey evidenced results of oxi­
dation of ciprofloxacin, enrofloxacin, lomefloxacin, 
norfloxacin, ofloxacin, pipemidic acid and flume- 
quine using MnO2 followed by evaluation of the
reaction kinetics and analysis of chemical structure 
of degradation products formed (4, 5).
Moxifloxacin, as well as ciprofloxacin, diflox- 
acin, lomefloxacin, norfloxacin and ofloxacin and 
theirs oxidation products during reaction with 
KMnO4 in acidic solution of pH ranging from 3.0 to 
6.0 were determined by UPLC-MS/MS. Mechanism 
of the process, the kinetic analysis and structures of 
oxidation products were presented in our recent pub­
lications (6, 7).
Moreover, an advanced oxidation technolo­
gies, notably ozonation of thirteen fluoroquinolone, 
including danofloxacin, enrofloxacin, pefloxacin 
and sparfloxacin with a secondary wastewater efflu­
ent matrix was also reported (8).
Similar studies were carried out for 
ciprofloxacin, enrofloxacin and flumequine in phos­
phate buffer solutions at pH values ranging from 3.0 
to 9.0. Moiety-specific reaction kinetics were meas-
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ured and elimination of biological activity during 
aqueous ozonation processes was investigated (9, 
10).
Another advanced oxidation process, electron 
pulse radiolysis, was studied for chemical degrada­
tion of danofloxacin, enrofloxacin, marbofloxacin, 
orbifloxacin and flumequine in buffer solution 
adjusted to pH 7.0. Kinetics and degradation mech­
anism were investigated. In addition, the products of 
Y irradation degradation of fluoroquinolones were 
analyzed by LC-MS to elucidate the probable path­
ways of advanced oxidation/reduction processes 
(AO/RPs) degradation (11).
Liu et al. studied the degradation products of 
danofloxacin under stressed conditions (hydrolysis, 
oxidation and photolysis). The oxidative study was 
carried out in 30% H2O2 at room temperature for 12
h. Seven degradation products were detected using 
hybrid ion trap/time-of-flight mass spectrometry 
(LC/MS-IT-TOF) (12).
Other advanced oxidation processes, catalytic 
wet air oxidation, anodic oxidation with electrogen­
erated H2O2, electro-Fenton, photoelectron-Fenton 
and solar photoelectron-Fenton, oxidation with H2O2 
in the presence of copper oxide, titanium carbide 
and silicon nitride nanoparticles as well as oxidation 
by chlorine dioxide and conductive-diamond elec­
trochemical oxidation, were studied for the chemical 
degradation of enrofloxacin in aqueous solution (13­
17). The primary degradation products formed dur­
ing the process have been identified (13-15).
Recently our interest focused on UPLC cou­
pled with mass spectrometry technique for the sepa­
ration and identification of oxidation products since 
the efficiency, sensitivity and run time became an 
important factor in the pharmaceutical analysis.
Herein, we report on the development of a new 
UPLC-MS/MS method for the determination of 
danofloxacin (DAN), enrofloxacin (ENR), mar- 
bofloxacin (MAR), orbifloxacin (ORB), pefloxacin 
(PEF) and their oxidation products during reaction 
with KMnO4 in solutions of different pH ranging 
from 3.0 to 6.0. The method was used for kinetic 
studies and identification of obtained degradation 
products of examined fluoroquinolones.
Potassium permanganate is widely used as an 
oxidizing agent in synthetic as well as in analytical 
chemistry and also as a disinfectant. Permanganate 
Mn(VII) is the most potent oxidation state in alkaline 
as well as in acid medium. The oxidation by per­
manganate ion finds extensive application in organic 
syntheses, especially since the advent of phase trans­
fer catalysis. Kinetic studies are important sources of 
mechanistic information on the reaction.
The presence and accumulation of fluoro­
quinolones in aquatic environments even at low 
concentrations may pose threats to the ecosystem 
and human health by inducing increase and spread 
of bacteria drug-resistance due to long-term expo­
sure. Chemical oxidation using permanganate has 
been widely used for treatment of pollutants in 
drinking water and wastewater applications for over 
50 years (18, 19).
In view of potential pharmaceutical importance 
of DAN, ENR, MAR, ORB and PEF and lack of the 
literature on this type of oxidation of examined 
drugs and the complexity of the reaction, a detailed 
study of the reaction becomes important. Our study 
deals with the title reaction to investigate the redox 
chemistry of permanganate in solutions of different 
pH and to arrive at a suitable mechanism for oxida­
tion of DAN, ENR, MAR, ORB and PEF by per­
manganate on the basis of kinetic results. It seems, 
that oxidation of model fluoroquinolones under 
KMnO4 in acidic medium, opens up the possibility 
for application in drug stability studies and environ­
mental protection studies in the process of utiliza­
tion of drug traces.
EXPERIMENTAL 
Chemicals and reagents
Danofloxacin Cat. No. 33700-100MG-R 
Sigma-Aldrich (Germany), Enrofloxacin Cat. No. 
OR6-237 Ranbaxy (Poland), Marbofloxacin CRS, 
European Pharmacopoeia Reference Standard, 
Council of Europe -  EDQM CS 30026 F-67081 
(France, Strasbourg, Cedex), Orbifloxacin Cat. No. 
34041-100M G-R Sigma-Aldrich (Germany), 
Pefloxacin mesylate dihydrate Cat. No. P0106-10G 
Sigma-Aldrich (Germany). HPLC grade methanol, 
acetonitrile and formic acid (98%) were purchased 
from J.T. Baker (Netherlands). HPLC grade water 
was obtained from HLP 5 (HYDROLAB Poland) 
apparatus and was filtered through 0.2 pm filter 
before use.
Standard solution
The amount of 0.2 g of all fluoroquinolones 
was weighed with a precision of 0.1 mg. PEF was 
dissolved in the volume of 50 mL of methanol, and 
filled up to 100 mL with the same solvent. The sam­
ple weight of DAN and ORB was dissolved in the 
volume of 5 mL of glacial acetic acid, and filled up 
to 100 mL with methanol. The sample weight of 
ENR was dissolved in 48 mL of methanol with the 
addition of 2 mL of chloroform, and filled up to 100 
mL with the same solvent. Solution of MAR was
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prepared by dissolving the amount of 0.2 g of MAR 
in the volume of 50 mL of methanol-water mixture 
(1 : 1, v/v), and filled up to 100 mL with the same 
solvent. For method validation, solutions containing 
different concentrations of the examined fluoro­
quinolones in the range 0.06-0.13 mg/mL were pre­
pared.
Oxidation study of the drug substance
The amount of 0.5 mL of methanol solutions of 
DAN, ENR, MAR, ORB, PEF (2.0 mg/mL), 2.5 mL 
demineralized water, 5.0 mL ammonium acetate 
buffer solution prepared according to European 
Pharmacopeia (16) with proper pH (3.0, 4.0, 4.5, 5.0 
or 6.0) and 2 mL 0.002 M KMnO4 was added to 10.0 
mL flasks. The test solutions were incubated at 
room temperature and 1 pL of each reaction mixture 
was injected onto ACQUITY UPLC system after 
15, 30, 45 and 60 min, respectively. Before the 
measurements of test samples, the analysis of solu­
tions containing identical components as test sam­
ples but without KMnO4 was done. The analyses 
were performed in triplicate.
UPLC/MS/MS analysis
The UPLC-MS/MS system consisted of a 
Waters ACQUITY® UPLC® (Waters Corporation, 
Milford, MA, USA) coupled to a Waters TQD mass 
spectrometer (electrospray ionization mode ESI-tan- 
dem quadrupole). Chromatographic separations 
were carried out using the Acquity UPLC BEH 
(bridged ethyl hybrid) C18 column; 2.1 x 100 mm, 
and 1.7 pm particle size. The column was main­
tained at 40OC, and eluted under gradient conditions 
using from 100% to 75% of eluent A over 10 min for 
DAN, ENR MAR, ORB or 95% to 75% of eluent A 
over 10 min for PEF, at a flow rate of 0.3 mL/min. 
Eluent A: 1% (v/v) formic acid in water; eluent B: 
0.1% (v/v) formic acid in acetonitrile.
Chromatograms were recorded using Waters 
eX PDA detector. Compound concentration (%i) 
after oxidation induced by KMnO4 was calculated 
from quotient of peak area (Ai) to the sum of all 
peaks areas (EA) on chromatograms according to 
formulation %i = (Ai/EA)100 at X = 294 nm. Spectra 
were analyzed in 200-700 nm range with 1.2 nm res­
olution and sampling rate 20 points/s.
MS detection settings of Waters TQD mass 
spectrometer were as follows: source temperature 
150OC, desolvation temperature 350OC, desolvation 
gas flow rate 600 L/h, cone gas flow 100 L/h, capil­
lary potential 3.00 kV, cone potential 20 V. 
Nitrogen was used for both nebulizing and drying 
gas. The data were obtained in a scan mode ranging
from 50 to 1000 m/z in time 0.5 s intervals; 8 scans 
were summed up to get the final spectrum.
Collision activated dissociations (CAD) analy­
ses were carried out with the energy of 30 eV, and 
all the fragmentations were observed in the source. 
Consequently, the ion spectra were obtained by 
scanning from 50 to 500 m/z range. Data acquisition 
software was MassLynx V 4.1 (Waters).
Method validation
The described method was validated for the 
determination of DAN, ENR, MAR, ORB and PEF 
in the presence of oxidation products by UPLC 
method according to ICH guidelines (20, 21).
Specificity
To demonstrate the specificity of the devel­
oped UPLC method the solutions of DAN, ENR, 
MAR, ORB, PEF after oxidation stress were ana­
lyzed. Oxidation study was performed in 0.002 M 
KMnO4 solution in ammonium acetate buffer at pH 
4.0; the solution was left for 15 min at room tem­
perature.
System suitability
The system suitability parameters were defined 
with respect to tailing factor and resolution of exam­
ined fluoroquinolones peaks using solutions of 
DAN, ENR, MAR, ORB, PEF, after oxidation stress 
at pH 4.0.
Linearity
The linearity for DAN, ENR, MAR, ORB, PEF 
was assessed by injecting six separately prepared 
solutions covering the range of 0.06-0.13 mg/mL. 
The slope of regression line, y-intercept, standard 
deviation of slope and intercept, correlation coeffi­
cient, R2 value and standard error of residuals of the 
calibration curve were calculated using the program 
Statistica v. 10. Next, to determine whether the 
residuals have normal distribution, the Shapiro-Wilk 
statistical test was used.
Limit o f  detection (LOD) and limit o f quantifica­
tion (LOQ)
Based on the standard error of residuals (Se) 
and the slope (a) of the calibration plots and follow­
ing the formula LOD = 3.3Se/a and LOQ = 10Se/a, 
the LOD and LOQ values for chosen fluoro­
quinolones were estimated.
Precision
The repeatability of the method was checked by 
a sixfold analysis of the concentration level 0.10
Table 1.Validation of the method.
Parameter DAN ENR MAR ORB PEF
tR fmin)a 7.19 ±0.05 7.49 ± 0.03 6.21 ±0.02 7.64 ± 0.06 5.37 ± 0.04
Resolutionь 6.00 5.50 1.33 6.40 7.00
LOD fmg/mL) 0.01 0.01 0.01 0.01 0.01
LOQ fmg/mL) 0.03 0.02 0.02 0.04 0.03
Linear range fmg/mL) 0 .06-0 .12 0 .07-0 .13 0 .06-0 .12 0 .06-0 .13 0 .06-0 .13
Regression equation (у):
Slope fa ± Sa) 189794.7 ± 5336.2 210743.2 ± 4944.8 346248.3 ±6511.1 35454.2 ± 12962.1 116615.0 ± 3335.4
Intercept fb ± Sb) -183.2 ±491.5 -1160.2 ±526.3 -1245.4 ± 582.4.5 -1453.7 ± 1287.9 -200.5 ±331.4
t = b/Sb
-0.37 < taf 
statistically 
insignificant
-2.20 < tLf 
statistically 
insignificant
-2.14 < t„.f 
statistically 
insignificant
-1.13 < taf 
statistically 
insignificant
-0.61 < tLf 
statistically 
insignificant
Shapiro-Wilk 
test for residuals 0.8747 fp = 0.07) 0.9568 fp = 0.75) 0.9157 fp = 0.32) 0.9273 fp = 0.35) 0.9128 fp = 0.23)
Correlation
coefficient 0.9996 0.9978 0.9986 0.9934 0.9959
R2 value 0.9989 0.9951 0.9968 0.9855 0.9911
Precision (% RSD) 0.56 0.89 0.51 0.82 0.48
Intermediate 
precision (% RSD) 1.10 1.21 0.93 1.18 1.01
ta f = 2.306 critical value of Student’s t-test for degrees of freedom f = 8 and significance level a  = 0.05.3 Mean ± SD (n = 6),b The mean values for n = 6. Resolutions were calculated between two adjacent peaks.
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Figure 1. UPLC chromatograms registered for fluoroquinolones after oxidation induced by KM nO 4 at pH  = 4.5: A, DAN tR = 7.24; B, ENR
tR = 7.50; C, M AR tR = 6.23; D, ORB tR = 7.68; E, PEF tR = 5.33
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mg/mL of DAN, ENR, MAR, ORB, PEF solutions. 
The same protocol was followed for three different 
days to study the intermediate precision of the pro­
posed method. Different analysts prepared different 
solutions on different days. The RSD (%) of the peak 
area of examined fluoroquinolones was calculated.
Robustness
To demonstrate the robustness of the method 
deliberate small changes of flow rate, content of ace­
tonitrile and column temperature were made around 
the optimal values. The mobile phase flow rate was
0.30 mL/min; to study the effect of the flow rate on 
resolution, the flow rate was changed to 0.27 and
0.33 mL/min. The effect of the column temperature 
was studied at 36OC and 44OC (instead of 40OC), and 
the mobile phase composition was changed +5% 
from the initial composition.
RESULTS AND DISCUSSION
Apart from hydrolysis and photostability 
assays, an influence of oxidizing agents in the 
process of forced degradation is an integral part of
Table 2. Oxidation reaction rate constant o f fluoroquinolones in solution at different pH.
Component pH Rate constant k 
[min-1]
Correlation 
coefficient r
PEF
3.0 3.00 X 10-4 0.9908
4.0 11.00 X 10-4 0.9596
5.0 11.00 X 10-4 0.9760
6.0 3.00 X 10-4 0.9994
MAR
3.0 3.00 X 10-4 0.9531
4.0 3.00 X 10-4 0.9852
5.0 3.00 X 10-4 0.9892
6.0 1.00 X 10-4 0.9833
ENR
3.0 0.65 X 10-4 0.9998
4.0 2.00 X 10-4 0.9967
5.0 2.00 X 10-4 0.9955
6.0 0.98 X 10-4 0.9837
DAN
3.0 2.00 X 10-4 0.9242
4.0 1.00 X 10-4 0.8537
5.0 2.00 X 10-4 0.8771
6.0 1.00 X 10-4 0.8303
ORB
3.0 0.35 X 10-4 0.9949
4.0 0.32 X 10-4 0.9678
5.0 0.27 X 10-4 0.9806
6.0 0.22 X 10-4 0.9774
Table 3. The kinetic results o f investigated fluoroquinolones under KM nO 4  oxidation at pH 4.5 at room  tem ­
perature.
Component Rate constant k[min-1]
k .1
[min]
h .5
[min]
Correlation 
coefficient r
DAN 2.00 X 10-4 5.56 50.00 0.9169
ENR 2.00 X 10-4 5.56 50.00 0.9788
MAR 3.00 X 10-4 3.70 33.33 0.9937
ORB 0.25 X 10-4 44.44 400.00 0.9709
PEF 10.00 X 10-4 1.11 10.00 0.9654
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stress studies used for the stability evaluation of 
pharmaceutical products and should be checked (3). 
This effect may be evaluated by using validated ana­
lytical procedures enabling the determination of 
decreasing concentration of examined substance and 
detection of degradation products.
Optimization of chromatographic conditions
The main target of the chromatographic 
method was to achieve the separation of oxidation 
products and the main components DAN, ENR, 
MAR, ORB and PEF. To optimize the chromato­
graphic separation, preliminary experiments were 
performed to test mobile phases containing different 
mixtures of acetonitrile and water (50/50, 83/17, 
75/25, v/v); always the same amount of mobile 
phase additive was used. The solutions of deter­
mined fluoroquinolones after oxidation stress 
(buffer solution at pH =  4.0, 30 min incubation) was 
analyzed. We took advantage of a mixture acetoni-
trile/water 83/17 (v/v), with 0.1% of formic acid to 
obtain good peak resolution and symmetry.
Method validation
The developed UPLC method was specific to 
examined fluoroquinolones and guaranteed obtain­
ing well shaped peaks both for active substances and 
coexisting oxidation products. Peaks of main com­
ponents were well resolved from oxidation products 
in chromatograms and no interference that could 
have an influence on the obtained results was possi­
ble (Table 1). The main peak purity was examined 
with MS spectra using CODA algorithm (Waters 
Corporation, Milford, MA, USA). The investigated 
MS spectra uniquely contained signals correspon­
ding to the chosen fluoroquinolones and solvent.
Satisfactory resolution was also obtained for 
oxidation products, peaks appearing in chro­
matograms were sufficiently well resolved and 
could be analyzed by mass spectrometry (Fig. 1).
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Figure 3. The ln k  = f  (pH) graph of oxidation of DAN, ENR, M AR, ORB and PEF induced by КМПО4
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Regression analysis results obtained for 
exam ined fluoroquinolones are presen ted  in 
Table 1. The correlation coefficients and deter­
m ination coefficients (R2) obtained for linear 
model for all determ ined fluoroquinolones were 
greater than 0.99. The y-intercepts of the linear 
equation for DAN, ENR, M AR, ORB and PEF 
were statistically insignificant. The distribution 
of the residuals can well be approxim ated with a 
normal distribution as it is shown by p-values (p 
> 0.05) of the Shapiro-W ilk norm ality test. Based
on regression analysis, it was assumed that the 
calibration  data fitted  w ell to linear model. 
Linearity range, was observed in the concentra­
tion range 0.06-0 .13 mg/mL for exam ined fluo­
roquinolones.
Sensitivity of the method was good. The LOD 
and LOQ values were found to be 0.01 mg/mL and 
from 0.02 to 0.04 mg/mL, respectively. Good preci­
sion and intermediate precision with %RSD less 
than 2.0% was observed. Detailed results are pre­
sented in Table 1. In all the deliberately varied chro­
1110 URSZULA HUBICKA et al.
matographic conditions (flow rate, column tempera­
ture, mobile phase composition), chosen fluoro­
quinolones and degradation products were adequate­
ly resolved, and the order of elution remained 
unchanged.
Oxidation of exam ined fluoroquinolones by 
KMnO4 in acidic medium
The effect of KMnO4 on the oxidation of DAN, 
ENR, MAR, ORB and PEF has been tested in solu­
tions of pH 3.0 to 6.0. It was found that the oxida­
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tion process is dependent on the pH of the solution, 
incubation time and the type of fluoroquinolone.
Immediately after mixing the solutions, only a  sin­
gle peak of fluoroquinolones deriving from starting 
materials were observed in chromatograms of the 
tested solutions. During the oxidation process, addi­
tional peaks appeared in chromatograms, whose 
area increased with increasing reaction time. After 
60 min of incubation, the ORB had three oxidation 
products (OP-1 - OP-3), DAN four oxidation prod­
ucts (DP-1 - DP-4), and in the case of ENR and PEF 
five oxidation products were observed (EP-1 - EP-5 
and PP-1 - PP-5). The highest number of the oxida­
tion products was obtained for MAR ( MP-1 - MP- 
7). Some chosen chromatograms presented in Figure 
1 show the degradation profile of DAN, ENR, 
MAR, PEF and ORB. Degradation process of tested 
fluoroquinolones increased with increasing acidity 
of the solution in the pH range from 6.0 to 3.0, gen­
erally reaching the highest values at pH 4.5. The 
percentage of degradation products in the final stage 
of oxidation after 60 min was as follows: 48.92% for
DAN, 59.51% for ENR, 62.74% for MAR, 13.5% 
for ORB and 85.33% for PEF.
Kinetic evaluation
The analysis of the equation 1 / c = f  ( t) for the 
oxidation of DAN, ENR, MAR, ORB and PEF in 
the pH range 3.0-6.0 demonstrated that oxidation 
process followed the kinetics of second order reac­
tion (Fig. 2). Calculated kinetic parameters for the 
oxidation reaction for individual fluoroquinolones 
suggest that the oxidation process is dependent on 
the pH of the reaction medium and the type of fluo­
roquinolone tested (Table 2). In solutions at pH = 
4.5 PEF oxidizes quickly -  k = 10.00 x 10-4/min, 
DAN and ENR -  k = 2.00 x 10-4/min in similar way 
but slower than MAR -  k = 3.00 x 10-4/min, while 
the slowest oxidation was observed for ORB -  k =
0.25 x10-4/min. The oxidation processes described 
by values t0.1 and t0.5 determining the time after 
which the concentration of the tested fluoro­
quinolone decreases, show that oxidation will pro­
ceed in the following order PEF > MAR > DAN =
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ENR > ORB (Table 3). Results of these studies con­
firm the degradation profiles, described by the equa­
tion ln k = f  (pH ), which are different and depend­
ent on the pH of the solutions of the individual com­
pounds and the type of examined fluoroquinolone 
from the smallest ORB to the largest PEF (Fig. 3).
Identification of oxidation products
The identification of oxidation products of five 
fluoroquinolones (DAN, ENR, MAR, ORB and 
PEF) induced by KMnO4 in acidic conditions was
performed on a basis of UPLC/MS analysis and sup­
ported by fragmentation patterns obtained from 
MS/MS experiments. As we have reported in our 
earlier paper (7), the oxidation process mainly affect 
the 7-amine substituent of fluoroquinolone moiety,
i.e., 5-ethyl-2,5-diazabicyclo[2.2.1]heptane, 4-eth- 
ylpiperazine, 4-methylpiperazine and 3,5-dimeth- 
ylpiperazine, while the fluoroquinolone core 
remains unchanged.
It was found that the main route of oxidation 
involved hydroxylation in the close vicinity of N-1 and
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N-4 piperazine atoms to respective hydroxylated deriv­
atives and subsequent oxidation to their oxo-counter- 
parts. For ENR, MAR and PEF, the main product of 
oxidation was 3-hydroxy derivative (EP-4, MP-3, PP- 
3), and 3,5-dihydroxy derivatives were also observed 
(EP-3, MP-2, PP-2). In case of ENR and MAR, the 
hydroxylactam derivatives (EP-2, MP-7), as products of 
further oxidation of piperazine moiety, were observed, 
although for ENR the intermediate step was dealkyla- 
tion of N -4 nitrogen atom. For DAN the most abundant 
product of oxidation was N-4 demethylated 2,3,5-trihy­
droxy derivative (DP-2), mono-hydroxy or di-hydroxy 
derivatives were not observed. In case of ORB, pos­
sessing piperazine moiety with 3 and 5 position substi­
tuted with methyl group, the main product of oxidation 
was 2-hydroxy derivative (OP-3). Oxidation of piper­
azine moiety of ORB in close vicinity to more basic N - 
4 nitrogen atom, leading to 3,5-dihydroxy derivative 
(OP-1), involved demethylation by oxidative C-C bond 
cleavage, and was 10-fold less effective than oxidation 
in position 2. Oxidative C-C bond cleavage occurred 
also in case of DAN, leading to 1,2,3,4-tetrahydro- 
pyrazine derivative (DP-3). Further oxidation of fluoro­
quinolones led to ring opening, dealkylation (e.g., M P­
4, MP-5, MP-6, PP-4) and finally yielded 7-amino 
quinolone products (DP-4, EP-5, PP-5). This product 
was not observed in case of MAR and OFL, probably 
due to the presence of electron-withdrawing sub­
stituents in both ortho positions of phenyl ring, i.e., flu­
orine and oxygen atoms in case of MAR and two fluo­
rine atoms in case of OFL, and hence lower basicity of 
N-1 nitrogen atom of piperazine moiety than in case of 
the other investigated fluoroquinolones.
The structures of presented stable oxidation 
products were confirmed by Collisionally Activated 
Decomposition (CAD) experiments. The fragmenta­
tion pattern involved loss of H2O from the carboxy- 
late group of quinolone, then loss of carboxylate 
function and piperazine ring degradation. Quinolone 
N-1 nitrogen dealkylation proceeded slowly, except 
for MAR, for which 3,4-dihydro-2Я-1,3,4-oxadi- 
azine ring easily underwent degradation processes. 
For ORB, cyclopropyl moiety seems to be stable, 
what may be attributed to an influence of electron- 
withdrawing of additional fluorine substituent in 
position 8 of quinolone. Proposed structures of oxi­
dation products of the examined fluoroquinolones 
are presented in Tables 4-8, for DAN, ENR, MAR, 
ORB, and PEF, respectively.
CONCLUSIONS
The elaborated method complies with the 
acceptance criteria for methods which can be useful
for the determination of DAN, ENR, MAR, ORB 
and PEF in the presence of its oxidation products. 
The method was completely validated showing sat­
isfactory data for all the parameters tested. Executed 
studies have shown that an oxidation process fol­
lowed kinetics of the second order reaction for the 
substrates. Kinetic parameters such as rate constants 
к and the times t01 and t0.5 depended on solution 
acidity and type of studied fluoroquinolones.
It was found, that the most susceptible fluoro­
quinolones for oxidation was PEF. DAN, ENR and 
MAR displayed lower degradation rate with compa­
rable t01 and t0.5 values, while ORB was the most sta­
ble among the tested drugs. The proposed model of 
investigation of oxidation profile for presented fluo­
roquinolones may be regarded as a predictor of their 
stability.
Degradation of fluoroquinolones mainly 
affected piperazine moiety giving respective 
hydroxy- and oxo-derivatives. Further oxidation of 
DAN, ENR, MAR and PEF, following dealkylation, 
and degradation of piperazine yielded 7-amino 
fluroquionolones analogs.
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